Neurega 75 mg (Capsule)
Unit Price: ৳ 18.00 (5 x 4: ৳ 360.00)
Strip Price: ৳ 72.00
Medicine Details
Category | Details |
---|---|
Generic | Pregabalin |
Company | Ibn sina pharmaceuticals ltd |
Also available as |
Title
- Neurega 75 mg Capsule
Categories
- Anticonvulsant
- Neurotic Pain Relief
- Seizure Management
- Anti-epileptic Drug
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Pharmacology
- Structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Binds with high affinity to the alpha2-delta site in central nervous system tissues
- Anti-nociceptive and antiseizure effects
Dosage
- Maximum recommended dose of Pregabalin is 100 mg three times a day
- Dosing should begin at 50 mg three times a day
- Dose may be increased based on efficacy and tolerability
Administration
- Oral route of administration
- Can be taken with or without food
- Swallowed whole, not split, crushed or chewed
Drug Interaction
- Unlikely to be involved in significant pharmacokinetic drug interactions
- No significant interactions with food and others
Contraindications
- Contraindicated in patients with known hypersensitivity to Pregabalin or any of its components
Side Effects
- Dizziness
- Somnolence
- Dry mouth
- Edema
- Blurred vision
- Weight gain
- Difficulty with concentration/attention
- Increased weight and appetite in pediatric patients
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Potential risk to a fetus
- Small amounts detected in the milk of lactating women
- Breastfeeding not recommended
Precautions & Warnings
- Angioedema can occur and may be associated with life threatening respiratory compromise
- Discontinue immediately in case of severe hypersensitivity reactions
- Increased risk of suicidal thoughts or behavior
- Respiratory depression may occur when used with concomitant CNS depressants
- May cause dizziness, somnolence, and impair driving ability
- Increased seizure frequency or adverse reactions upon rapid discontinuation
Use in Special Populations
- Safety and effectiveness not established in pediatric patients
- Safety and effectiveness for partial onset seizures not established in pediatric patients below 1 month of age
Overdose Effects
- Signs and symptoms include reduced consciousness, depression/anxiety, agitation, restlessness, seizures, and heart block
- No specific antidote
- General supportive care indicated
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Keep in a cool & dry place (below 30°C)
- Protected from light & moisture
- Keep out of the reach of children
Compound Summary
- Molecular Formula: C8H17NO2
Common Questions
- First-line treatment for neurotic pain, shingles, seizures, and fibromyalgia
- Duration of use determined by improvement in health conditions
- Administration frequency as prescribed by the doctor
- Should be taken after food, stored in original packaging away from children and pets
- Works differently for different diseases
- Duration of use depends on the specific condition
- Should not be stopped suddenly without consulting the doctor